GeneQuine’s CEO Kilian Guse to Discuss Advances in Cell and Gene Therapy in Panel Discussion at the Sachs 16th Annual Biotech in Europe Forum, 27 - 28 September 2016, Basel [ 21 Sep 2016 ]

Kilian Guse will discuss advances in cell and gene therapies with other leaders in the field and present GeneQuine’s development programs.

GeneQuine’s CEO Kilian Guse to Discuss Advances in Cell and Gene Therapy in Panel Discussion at the Sachs 16th Annual Biotech in Europe Forum, 27  - 28 September 2016, Basel

The Sachs Biotech in Europe Forum is an international stage for those interested in investing and partnering in the biotech and life science industry. The Forum offers plenty of opportunity for networking including 1-2-1 meetings.

Back